NRIX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Nurix Therapeutics (NRIX) Earnings Date & Reports

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NRIX is expected to report earnings to -75 cents per share on April 09

Nurix Therapeutics NRIX Stock Earnings Reports

Q1'25

Est.

$-0.76

Q4'24

Missed

by $0.07

Q3'24

Est.

$-0.67

Q2'24

Missed

by $0.08

Q1'24

Beat

by $0.02

The last earnings report on January 28 showed earnings per share of -75 cents, missing the estimate of -68 cents. With 836.69K shares outstanding, the current market capitalization sits at 801.24M.

View a ticker or compare two or three

Compare

NRIX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NRIX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NRIX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1700 Owens Street

Phone

+1 415 660-5320

Employees

284

Web

http://www.nurixtx.com